These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12727114)

  • 21. Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium?
    Chanséaume S; Azarnoush K; Maurel A; Bellamy V; Peyrard S; Bruneval P; Hagège AA; Menasché P
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):293-7. PubMed ID: 17669846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.
    Déglon N; Heyd B; Tan SA; Joseph JM; Zurn AD; Aebischer P
    Hum Gene Ther; 1996 Nov; 7(17):2135-46. PubMed ID: 8934227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions.
    Schwenter F; Schneider BL; Pralong WF; Déglon N; Aebischer P
    Hum Gene Ther; 2004 Jul; 15(7):669-80. PubMed ID: 15242527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts.
    Güttinger M; Padrun V; Pralong WF; Boison D
    Exp Neurol; 2005 May; 193(1):53-64. PubMed ID: 15817264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells.
    Acarregui A; Pedraz JL; Blanco FJ; Hernández RM; Orive G
    Biomacromolecules; 2013 Feb; 14(2):322-30. PubMed ID: 23231457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans.
    Skuk D; Goulet M; Roy B; Tremblay JP
    Exp Neurol; 2002 May; 175(1):112-26. PubMed ID: 12009764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of myoblast microencapsulation for gene therapy.
    Li AA; Shen F; Zhang T; Cirone P; Potter M; Chang PL
    J Biomed Mater Res B Appl Biomater; 2006 May; 77(2):296-306. PubMed ID: 16470809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irradiation of dystrophic host tissue prior to myoblast transfer therapy enhances initial (but not long-term) survival of donor myoblasts.
    Hodgetts SI; Grounds MD
    J Cell Sci; 2003 Oct; 116(Pt 20):4131-46. PubMed ID: 12972504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
    Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J
    Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules.
    De Castro M; Orive G; Hernández RM; Bartkowiak A; Brylak W; Pedraz JL
    J Biomed Mater Res A; 2009 Dec; 91(4):1119-30. PubMed ID: 19145624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
    Wen J; Vargas AG; Ofosu FA; Hortelano G
    J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin gel improves the survival of transplanted myoblasts.
    Gerard C; Forest MA; Beauregard G; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(1):127-37. PubMed ID: 21535909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epo delivery by genetically engineered C2C12 myoblasts immobilized in microcapsules.
    Murua A; Orive G; Hernandez RM; Pedraz JL
    Adv Exp Med Biol; 2010; 670():54-67. PubMed ID: 20384218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.
    Rinsch C; Quinodoz P; Pittet B; Alizadeh N; Baetens D; Montandon D; Aebischer P; Pepper MS
    Gene Ther; 2001 Apr; 8(7):523-33. PubMed ID: 11319619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
    Hodgetts SI; Grounds MD
    Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term erythropoietin gene expression from transduced cells in bioisolator devices.
    Yanay O; Barry SC; Flint LY; Brzezinski M; Barton RW; Osborne WR
    Hum Gene Ther; 2003 Nov; 14(17):1587-93. PubMed ID: 14633401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CellMAC: a novel technology for encapsulation of mammalian cells in cellulose sulfate/pDADMAC capsules assembled on a transient alginate/Ca2+ scaffold.
    Weber W; Rinderknecht M; Daoud-El Baba M; de Glutz FN; Aubel D; Fussenegger M
    J Biotechnol; 2004 Nov; 114(3):315-26. PubMed ID: 15522441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transplantation of normal or genetically modified myoblasts for the treatment of hereditary or acquired diseases].
    Tremblay JP; Vilquin JT
    J Soc Biol; 2001; 195(1):29-37. PubMed ID: 11530497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.